Display options
Cite
Rossi L, Vakiarou F, Zoratto F, et al. Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC). Cancer Manag Res. 2013;5:377-85doi: 10.2147/CMAR.S47986.
Rossi, L., Vakiarou, F., Zoratto, F., Bianchi, L., Papa, A., Basso, E., Verrico, M., Lo Russo, G., Evangelista, S., Rinaldi, G., Perrone-Congedi, F., Spinelli, G. P., Stati, V., Caruso, D., Prete, A., & Tomao, S. (2013). Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC). Cancer management and research, 5377-85. https://doi.org/10.2147/CMAR.S47986
Rossi, Luigi, et al. "Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)." Cancer management and research vol. 5 (2013): 377-85. doi: https://doi.org/10.2147/CMAR.S47986
Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S. Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC). Cancer Manag Res. 2013 Nov 19;5:377-85. doi: 10.2147/CMAR.S47986. PMID: 24399885; PMCID: PMC3875371.
Copy Download .nbib Format: NLM
Share it on

Cancer Manag Res. 2013 Nov 19;5:377-85. doi: 10.2147/CMAR.S47986.

Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC).

Cancer management and research

Luigi Rossi, Foteini Vakiarou, Federica Zoratto, Loredana Bianchi, Anselmo Papa, Enrico Basso, Monica Verrico, Giuseppe Lo Russo, Salvatore Evangelista, Guilia Rinaldi, Francesca Perrone-Congedi, Gian Paolo Spinelli, Valeria Stati, Davide Caruso, Alessandra Prete, Silverio Tomao

Affiliations

  1. Department of Medico-Surgical Sciences and Biotechnologies, "Sapienza" University of Rome, Rome, Italy; Oncology Unit, ICOT, Latina, Italy.

PMID: 24399885 PMCID: PMC3875371 DOI: 10.2147/CMAR.S47986

Abstract

Management of metastatic colorectal cancer requires a multimodal approach and must be performed by an experienced, multidisciplinary expert team. The optimal choice of the individual treatment modality, according to disease localization and extent, tumor biology, and patient clinical characteristics, will be one that can maintain quality of life and long-term survival, and even cure selected patients. This review is an overview of the different therapeutic approaches available in metastatic colorectal cancer, for the purpose of defining personalized therapeutic algorithms according to tumor biology and patient clinical features.

Keywords: metastatic colorectal cancer; multidisciplinary approach; patient clinical features; tumor biology

References

  1. J Clin Oncol. 2006 Jan 20;24(3):394-400 - PubMed
  2. J Clin Oncol. 2007 Apr 20;25(12):1539-44 - PubMed
  3. Int J Colorectal Dis. 2012 Aug;27(8):997-1004 - PubMed
  4. Lancet. 2011 Jun 18;377(9783):2103-14 - PubMed
  5. J Clin Oncol. 1992 Jun;10(6):896-903 - PubMed
  6. J Clin Oncol. 2007 May 1;25(13):1658-64 - PubMed
  7. Lancet Oncol. 2010 Jan;11(1):38-47 - PubMed
  8. J Clin Oncol. 2005 Aug 1;23(22):4866-75 - PubMed
  9. J Clin Oncol. 2012 Oct 1;30(28):3499-506 - PubMed
  10. Lancet Oncol. 2013 Jan;14(1):29-37 - PubMed
  11. J Clin Oncol. 2008 Apr 20;26(12):2013-9 - PubMed
  12. Ann Oncol. 2011 Apr;22(4):947-956 - PubMed
  13. J Clin Oncol. 2010 Nov 1;28(31):4706-13 - PubMed
  14. Ann Oncol. 2005 Mar;16(3):425-9 - PubMed
  15. J Natl Cancer Inst. 2011 Jan 5;103(1):21-30 - PubMed
  16. N Engl J Med. 2004 Jun 3;350(23):2335-42 - PubMed
  17. Lancet. 2008 Mar 22;371(9617):1007-16 - PubMed
  18. Expert Rev Anticancer Ther. 2011 Oct;11(10):1567-75 - PubMed
  19. Ann Oncol. 2012 Oct;23(10):2479-2516 - PubMed
  20. J Clin Oncol. 2005 Dec 20;23(36):9243-9 - PubMed
  21. J Clin Oncol. 2008 May 10;26(14):2311-9 - PubMed
  22. J Clin Oncol. 2008 Apr 1;26(10):1626-34 - PubMed
  23. Ann Oncol. 2005 Aug;16(8):1311-9 - PubMed
  24. J Clin Oncol. 2009 Dec 1;27(34):5727-33 - PubMed
  25. Lancet. 2013 Jan 26;381(9863):303-12 - PubMed
  26. J Clin Oncol. 2004 Jan 15;22(2):229-37 - PubMed
  27. Surg Oncol Clin N Am. 2003 Jan;12(1):165-92, xi - PubMed
  28. Oncol Rep. 2012 Jun;27(6):1849-56 - PubMed
  29. J Clin Oncol. 2012 May 20;30(15):1755-62 - PubMed
  30. J Clin Oncol. 2011 May 20;29(15):2011-9 - PubMed
  31. J Clin Oncol. 2007 Sep 20;25(27):4224-30 - PubMed
  32. J Clin Oncol. 2008 Nov 20;26(33):5320-1 - PubMed
  33. Oncologist. 2012;17(1):15-25 - PubMed
  34. Lancet Oncol. 2010 Sep;11(9):845-52 - PubMed
  35. N Engl J Med. 2004 Jul 22;351(4):337-45 - PubMed
  36. Ann Oncol. 2009 Jun;20(6):985-92 - PubMed
  37. J Clin Oncol. 2009 Feb 10;27(5):663-71 - PubMed
  38. J Clin Oncol. 2010 Nov 1;28(31):4697-705 - PubMed
  39. Ann Oncol. 2008 May;19(5):920-6 - PubMed
  40. Ann Oncol. 2004 Jun;15(6):933-9 - PubMed

Publication Types